Ftse Mib
33.089,72
-0,23%
DAX
19.261,75
-0,22%
S&P 500
5.998,74
-0,38%
NASDAQ
19.060,48
-0,60%
Bitcoin
95.540,14
-0,46%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Biomerica Inc (BMRA) Biomerica Inc (BMRA) Notizie

Biomerica Inc

BMRA
0,4546
0,152 (50,23%)
28 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/11/202423:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/11/202414:19GLOBEBiomerica Secures Three Key International Patents for..
14/11/202422:19EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202415:09GLOBENasdaq grants Biomerica an additional 180 days to meet..
06/11/202423:20EDGAR2Form 8-K - Current report
30/10/202413:19GLOBEBiomerica Announces Direct-to-Consumer Availability of..
16/10/202415:00GLOBEBiomerica Reports First Quarter Fiscal 2025 Financial..
15/10/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/9/202423:00EDGAR2Form DEF 14A - Other definitive proxy statements
20/9/202423:00EDGAR2Form PRE 14A - Other preliminary proxy statements
04/9/202414:19GLOBEThe Saudi Food and Drug Authority (SFDA) Approves..
29/8/202415:00GLOBEBiomerica Reports Fiscal 2024 Year End Results
28/8/202423:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/7/202413:47GLOBEBiomerica Launches At-Home Sample Collection for inFoods®..
13/5/202414:19GLOBEBiomerica Announces inFoods® IBS Pilot Launch with Prominent..
10/5/202423:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/5/202423:15EDGAR2Form 8-K - Current report
29/4/202414:19GLOBEBiomerica and Leading UAE Healthcare Company Forge a Path to..
15/4/202413:47GLOBEBiomerica provides update on inFoods® IBS expansion
13/4/202401:23GLOBEBiomerica Reports Third Quarter 2024 Financial Results
28/3/202413:19GLOBEBiomerica InFoods IBS Data to be Presented at the Upcoming..
21/2/202414:19GLOBEDiagnostics Industry Leader Gary Huff Appointed to Biomerica..
14/2/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202421:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
23/1/202414:19GLOBEDiagnostics Industry Leader Jack Kenny Appointed as Chairman..
16/1/202414:19GLOBEBiomerica Reports Second Quarter 2024 Financial Results
16/1/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18/12/202313:47GLOBEBiomerica Received US FDA 510(k) Clearance for Their Hp..
14/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:19EDGAR2Form 8-K - Current report
11/12/202323:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,3026 Min: 0,3026 Max: 0,34
Chiusura: 0,3026

La tua Cronologia

NASDAQ
BMRA
Biomerica
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network